IL-6 and IL-1 synergistically enhanced the production of MMPs from synovial cells by up-regulating IL-6 production and IL-1 receptor I expression.
about
Decrease of CD68 Synovial Macrophages in Celastrol Treated Arthritic RatsInflammation induced loss of skeletal musclePotential role of fibroblast-like synoviocytes in joint damage induced by Brucella abortus infection through production and induction of matrix metalloproteinases.The roles of interleukin-6 in the pathogenesis of rheumatoid arthritis.A Network Pharmacology Approach to Uncover the Pharmacological Mechanism of XuanHuSuo Powder on Osteoarthritis.Tocilizumab, a humanized anti-interleukin-6 receptor antibody, for treatment of rheumatoid arthritis.Interleukin 6 and rheumatoid arthritisIL-6/IL-6 receptor system and its role in physiological and pathological conditions.Subcutaneous formulation of tocilizumab for treatment of rheumatoid arthritis.Selected cytokine pathways in rheumatoid arthritis.Blockade of interleukin-6 receptor enhances the anti-arthritic effect of glucocorticoids without decreasing bone mineral density in mice with collagen-induced arthritis.A Polyphenol-rich Pomegranate Fruit Extract Suppresses NF-κB and IL-6 Expression by Blocking the Activation of IKKβ and NIK in Primary Human Chondrocytes.Histone deacetylase inhibitor vorinostat (SAHA, MK0683) perturb miR-9-MCPIP1 axis to block IL-1β-induced IL-6 expression in human OA chondrocytes.Intercellular adhesion molecule-1 on synovial cells attenuated interleukin-6-induced inhibition of osteoclastogenesis induced by receptor activator for nuclear factor κB ligand.Ilomastat, a synthetic inhibitor of MMPs, prevents lung injury induced by γ-ray irradiation in mice.Interleukin-6 and chondrocyte mineralisation act in tandem to promote experimental osteoarthritis.Harpagoside suppresses IL-6 expression in primary human osteoarthritis chondrocytes.
P2860
Q27345563-4FB4171C-65FE-4885-AD08-B0CDADF41DAFQ28083759-CD409A8C-8FEC-4035-B9CF-949DEAA1AF77Q35191918-B58B1EE3-BB09-4525-AAF0-1A0F4A9AA70CQ35429154-4573B69B-863D-4E95-A75A-12F2E4ABFF5CQ36773475-BCA24061-180F-4AF1-8E79-1B3A7D19B451Q37358242-071C7C00-2D76-4219-BBE6-F9465EABB826Q37553940-F9196856-9ACB-4D01-BCBC-1FBD06E714ADQ37949664-05702418-26D5-4B13-A26B-52274C80647EQ38411334-A910C7E8-4A8F-421C-AC1B-7736091C0F85Q38755912-AAF60394-FAC3-4A7E-8025-E27C994D7519Q38850404-3BFCDBC4-5576-485B-A56D-442E8EBEFAD5Q38919125-15FDCC9C-E5E1-4ECB-87A7-A86AAD378C16Q39609958-C5C24443-2E89-4182-BA82-9BD10185B273Q39637547-E5C692EF-6BC2-4575-B261-162751857A3EQ42365246-2B3CFDC7-768B-48D0-805E-FCC6868F9B0DQ46280311-06338803-E5D1-4BEC-9E4D-F93BDFEE9D5CQ46563144-1F2B4774-F0FF-4632-A707-3344DA7E74D7
P2860
IL-6 and IL-1 synergistically enhanced the production of MMPs from synovial cells by up-regulating IL-6 production and IL-1 receptor I expression.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
IL-6 and IL-1 synergistically ...... nd IL-1 receptor I expression.
@en
IL-6 and IL-1 synergistically ...... nd IL-1 receptor I expression.
@nl
type
label
IL-6 and IL-1 synergistically ...... nd IL-1 receptor I expression.
@en
IL-6 and IL-1 synergistically ...... nd IL-1 receptor I expression.
@nl
prefLabel
IL-6 and IL-1 synergistically ...... nd IL-1 receptor I expression.
@en
IL-6 and IL-1 synergistically ...... nd IL-1 receptor I expression.
@nl
P2093
P1433
P1476
IL-6 and IL-1 synergistically ...... nd IL-1 receptor I expression.
@en
P2093
Hiroto Yoshida
Masahiko Mihara
Masashi Shiina
Miho Suzuki
Misato Hashizume
P304
P356
10.1016/J.CYTO.2010.03.017
P577
2010-04-18T00:00:00Z